Bangkok, Thailand

Thaiwatchai Santisuk

This inventor holds 1 USPTO granted patent. Top assignee: Zentaris Ag. Active years: 2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Thaiwatchai Santisuk. Retrieved from https://idiyas.com/inventor/thaiwatchai-santisuk

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 9(Granted Patents)


Company Filing History:


Years Active: 2002

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Thaiwatchai Santisuk

Introduction

Thaiwatchai Santisuk is a notable inventor based in Bangkok, Thailand. He has made significant contributions to the field of medicinal chemistry, particularly through his innovative work on xanthone compounds. His research focuses on the preparation and application of these compounds as potential anticancer agents.

Latest Patents

Thaiwatchai Santisuk holds a patent for "Xanthone compounds, their preparation and use as medicament." This invention pertains to the isolation of a novel xanthone natural product known as sootepenseone from the Annonaceae family. The patent details the identification and derivatization of sootepenseone, emphasizing its potential use as an anticancer agent.

Career Highlights

Thaiwatchai Santisuk is associated with Zentaris AG, where he continues to advance his research in medicinal applications of xanthone compounds. His work has garnered attention for its potential impact on cancer treatment.

Collaborations

He has collaborated with notable colleagues, including Vichai Reutrakul and Gerhard Noessner, to further enhance the scope and application of his research.

Conclusion

Thaiwatchai Santisuk's innovative work in the field of xanthone compounds showcases his commitment to advancing medicinal chemistry. His contributions have the potential to significantly impact cancer treatment and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…